Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Copolov

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Schizophrenia Research|May 18, 2016
Understanding the pathophysiology of schizophrenia: Contributions from the Melbourne Psychiatric Brain BankBrian Dean, David Copolov, Elizabeth Scarr
The Australian and New Zealand Journal of Psychiatry|March 13, 2025
Transforming mental health facilities: Current trends and considerationsVlasios Brakoulias, Vinay Lakra, David Copolov
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 5, 2005
Clozapine decreases [3H] CP 55940 binding to the cannabinoid 1 receptor in the rat nucleus accumbensSuresh Sundram, David Copolov, Brian Dean
The Australian and New Zealand Journal of Psychiatry|December 27, 2025
Specialisation of psychiatric services can deliver more effective person-centred careVlasios Brakoulias, Vinay Lakra, David Copolov
Schizophrenia Research|May 18, 2004
On the non-significance of internal versus external auditory hallucinationsDavid Copolov, Tom Trauer, Andrew Mackinnon
The Lancet. Psychiatry|September 24, 2019
Psychiatric bed numbers in AustraliaStephen Allison, Tarun Bastiampillai, David Copolov, et al.
Brain Research. Molecular Brain Research|September 13, 2002
The heterogeneity of central benzodiazepine receptor subtypes in the human hippocampal formation, frontal cortex and cerebellum using [3H]flumazenil and zolpidemMark McLeod, Daniele Pralong, David Copolov, et al.
Schizophrenia Research|October 12, 2004
Hippocampal 5-hydroxytryptamine receptors: abnormalities in postmortem brain from schizophrenic subjectsElizabeth Scarr, Geoffrey Pavey, David Copolov, et al.
The Australian and New Zealand Journal of Psychiatry|December 22, 2023
Seven decades of antipsychotic drugs: Why is the life of Australians with schizophrenia still so suboptimal?David Castle, David Copolov, Bruce Singh, et al.
Journal of Affective Disorders|June 5, 2003
Studies on serotonergic markers in the human hippocampus: changes in subjects with bipolar disorderBrian Dean, Elizabeth Scarr, Geoffrey Pavey, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Schizophrenia Research|May 18, 2016
Understanding the pathophysiology of schizophrenia: Contributions from the Melbourne Psychiatric Brain BankBrian Dean, David Copolov, Elizabeth Scarr
The Australian and New Zealand Journal of Psychiatry|March 13, 2025
Transforming mental health facilities: Current trends and considerationsVlasios Brakoulias, Vinay Lakra, David Copolov
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 5, 2005
Clozapine decreases [3H] CP 55940 binding to the cannabinoid 1 receptor in the rat nucleus accumbensSuresh Sundram, David Copolov, Brian Dean
The Australian and New Zealand Journal of Psychiatry|December 27, 2025
Specialisation of psychiatric services can deliver more effective person-centred careVlasios Brakoulias, Vinay Lakra, David Copolov
Schizophrenia Research|May 18, 2004
On the non-significance of internal versus external auditory hallucinationsDavid Copolov, Tom Trauer, Andrew Mackinnon
The Lancet. Psychiatry|September 24, 2019
Psychiatric bed numbers in AustraliaStephen Allison, Tarun Bastiampillai, David Copolov, et al.
Brain Research. Molecular Brain Research|September 13, 2002
The heterogeneity of central benzodiazepine receptor subtypes in the human hippocampal formation, frontal cortex and cerebellum using [3H]flumazenil and zolpidemMark McLeod, Daniele Pralong, David Copolov, et al.
Schizophrenia Research|October 12, 2004
Hippocampal 5-hydroxytryptamine receptors: abnormalities in postmortem brain from schizophrenic subjectsElizabeth Scarr, Geoffrey Pavey, David Copolov, et al.
The Australian and New Zealand Journal of Psychiatry|December 22, 2023
Seven decades of antipsychotic drugs: Why is the life of Australians with schizophrenia still so suboptimal?David Castle, David Copolov, Bruce Singh, et al.
Journal of Affective Disorders|June 5, 2003
Studies on serotonergic markers in the human hippocampus: changes in subjects with bipolar disorderBrian Dean, Elizabeth Scarr, Geoffrey Pavey, et al.
Pageof 5